Mechanism of action of natural products used in the treatment of diabetes mellitus

被引:0
作者
Pranav Kumar Prabhakar
Mukesh Doble
机构
[1] Indian Institute of Technology Madras,Department of Biotechnology
来源
Chinese Journal of Integrative Medicine | 2011年 / 17卷
关键词
hyperglycemia; medicinal plants; ginseng; bitter melon; fenugreek; banaba;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetes mellitus (DM) is a metabolic disorder caused by insufficient or inefficient insulin secretary response and it is characterized by increased blood glucose levels (hyperglycemia). DM is a heterogonous group of syndromes. Glucose is the main energy source for the body, and in the case of DM, management of glucose becomes irregular. There are three key defects in the onset of hyperglycemia in DM, namely increased hepatic glucose production, diminished insulin secretion, and impaired insulin action. Conventional drugs treat diabetes by improving insulin sensitivity, increasing insulin production and/or decreasing the amount of glucose in blood. This article provides a comprehensive review of the mode of action of most popular hypoglycemic herbs, such as ginseng, bitter melon, fenugreek, banaba, Gymnema sylvestre and Coptis chinensis. The herbs act by increasing insulin secretion, enhancing glucose uptake by adipose and skeletal muscle tissues, inhibiting intestinal glucose absorption and inhibiting hepatic glucose production. Although evidence from animals and humans consistently supports the therapeutic effect of these phytomedicines, multicenter large-scale clinical trials have not been conducted to evaluate the safety and efficacy of these herbal medicines and their interaction with conventional drugs when administered simultaneously.
引用
收藏
页码:563 / 574
页数:11
相关论文
共 359 条
  • [41] Spann S.J.(2008)Hypoglycaemic activity of Chem Biol 15 263-27
  • [42] Hui H.(2003) and Altern Med Rev 8 20-1093
  • [43] Dotta F.(2003) in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase J Nutr 133 1088-81
  • [44] Di Mario U.(2008)Bitter gourd ( Endocr Metab Immun Disord Drug Targets 8 76-2264
  • [45] Perfetti R.(2006)) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells Diabetes 55 2256-1176
  • [46] Kameswararao B.(2008)Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPAR-alpha in bitter gourd ( Biol Pharm Bull 31 1169-4518
  • [47] Kesavulu M.M.(2008) L.) Endocrinology 149 4510-119
  • [48] Apparao C.(2009)Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway Metabolism 58 109-712
  • [49] Middleton E.(2008)Therapeutic applications of fenugreek Chin Med J (Engl) 121 706-1418
  • [50] Kandaswami C.(2008)Bitter melon ( Diabetes 57 1414-717